Pro Share Advisors LLC Affimed N.V. Transaction History

Pro Share Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 25, 2023	BUY	$0.66 - $1.29 $17,878 - $34,944	27,089 New	27,089 $20,000
Q4 2022 Feb 02, 2023	BUY	$1.1 - $2.45 $3,124 - $6,958	2,840 Added 10.06%	31,077 $38,000
Q3 2022 Nov 04, 2022	BUY	$1.96 - $3.32 $1,244 - $2,108	635 Added 2.3%	28,237 $58,000
Q2 2022 Aug 01, 2022	SELL	$2.27 - $4.86 $14,893 - $31,886	-6,561 Reduced 19.2%	27,602 $76,000
Q1 2022 May 10, 2022	SELL	$3.69 - $5.65 $29,763 - $45,572	-8,066 Reduced 19.1%	34,163 $149,000
Q4 2021 Feb 08, 2022	BUY	$5.37 - $7.07 $10,433 - $13,737	1,943 Added 4.82%	42,229 $232,000
Q3 2021 Nov 12, 2021	SELL	$5.54 - $7.51 $62,064 - $84,134	-11,203 Reduced 21.76%	40,286 $249,000
Q2 2021 Aug 13, 2021	BUY	$7.78 - $11.4 $42,206 - $61,845	5,425 Added 11.78%	51,489 $438,000
Q1 2021 May 14, 2021	BUY	$5.12 - $8.48 $69,596 - $115,268	13,593 Added 41.86%	46,064 $364,000
Q4 2020 Feb 09, 2021	BUY	$3.16 - $7.03 $28,079 - $62,468	8,886 Added 37.68%	32,471 $189,000
Q3 2020 Nov 13, 2020	BUY	$3.26 - $4.73 $4,652 - $6,749	1,427 Added 6.44%	23,585 $80,000
Q2 2020 Aug 03, 2020	BUY	$1.58 - $4.63 $11,630 - $34,081	7,361 Added 49.75%	22,158 $102,000
Q1 2020 May 15, 2020	SELL	$1.44 - $3.02 $16,788 - $35,210	-11,659 Reduced 44.07%	14,797 $23,000
Q4 2019 Feb 12, 2020	BUY	$2.25 - $3.07 $59,526 - $81,219	26,456 New	26,456 $72,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.